REV 25 mg (Revlimid 25 mg)

Generic Name: lenalidomide

This pill with imprint "REV 25 mg" is White, Capsule-shape and has been identified as Revlimid 25 mg. It is manufactured by Celgene Corporation.

Revlimid is used in the treatment of multiple myeloma; myelodysplastic diseases; lymphoma; anemia; mantle cell lymphoma and belongs to the drug classes miscellaneous antineoplastics, other immunosuppressants. Not for use in pregnancy. Revlimid 25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Revlimid

Generic Name:

lenalidomide

Imprint:

REV 25 mg

Strength:

25 mg

Color:

White

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Miscellaneous antineoplastics
Other immunosuppressants

Pregnancy Category:

X - Not for use in pregnancy

CSA Schedule:

Not a controlled drug

Manufacturer:

Celgene Corporation

National Drug Code (NDC):

59572-0425

Inactive Ingredients:

lactose anhydrous
microcrystalline cellulose
croscarmellose sodium
magnesium stearate

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.